Population Pharmacokinetics and Exposure‐Response Model‐Based Bayesian Extrapolation of <scp>FVC</scp> ‐Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib
ABSTRACT Nintedanib reduces the rate of decline in forced vital capacity (FVC) in adult patients with idiopathic pulmonary fibrosis (IPF), chronic progressive‐fibrosing intersti...